Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation



Status:Archived
Conditions:Blood Cancer, Hematology
Therapuetic Areas:Hematology, Oncology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:May 2010

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Phase II, Multi-center, Non-randomized, Open-label Study of TKI258 in Patients With Relapsed or Refractory Multiple Myeloma, Who Are With or Without t(4;14) Translocation


This study will evaluate safety and efficacy of TKI258 in patients with relapsed or
refractory multiple myeloma



We found this trial at
2
sites
University Of Tennesse Cancer Institute
Memphis, Tennessee 38104
?
mi
from
Memphis, TN
Click here to add this to my saved trials
Lancanster Cancer Center
Lancaster, Pennsylvania 17601
?
mi
from
Lancaster, PA
Click here to add this to my saved trials